மருத்துவ தொற்று நோய்கள்: திறந்த அணுகல்

A Pan Genome Review on Drug Resistance Mutations of Mycobacterium Tuberculosis; An Impending Threat to Healthcare

Abstract

Deepali VP, Shreeya SR, Arjun M and Vidya Niranjan*

Tuberculosis, a bacterial infection caused by the organism Mycobacterium Tuberculosis, is a widespread disease infecting roughly one-fourth of the world’s population. Although a majority of these cases remain asymptomatic, tuberculosis continues to be the second- most common cause of death by infectious disease worldwide. A growing problem that is being exacerbated by the excessive use of multiple types of antibiotics is the emergence of drug resistant strains of tuberculosis. The number of Multiple Drug-Resistant Tuberculosis (MDR-TB) and Extensively Drug Resistant Tuberculosis (XDR-TB) strains are steadily increasing, rendering conventional treatment options ineffective. In order to circumvent the issue of drug-resistance, it is imperative that we understand both the mechanisms involved in resistance and the genetic mutations that cause it. In this review we delve into the important genes involved in drug resistance against common treatment options. We delineate the mechanism of resistance and specify the types and positions of mutations that have been observed in multiple studies worldwide. Finally, we discuss the relevance of the study to drug design, drug targeting and potentially forecasting future mutations by combining the mutation data with predictive analytics.